A Korean female had serious side effects after AZ+BNT COVID-19 vaccinated
- MIT: Potent New Strategies Enhancing COVID-19 RNA Vaccines
- Long-COVID Found to Have Surprising Connection with Common Cold
- AI Accelerates Deep Brain Stimulation for Treatment-Resistant Depression
- Fentanyl and Stimulant Abuse Lead to the 4th Wave of Overdose Crisis
- New Gene Editing Tool Reduces Accidental Mutations by Over 70%
- What role do Macrophages play in Tumor Immunotherapy?
A Korean female had serious side effects after AZ+BNT COVID-19 vaccinated
- Nearly 300 People Food Poisoning in Japanese 130-Year Restaurant
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
A Korean female had serious side effects after AZ+BNT COVID-19 vaccinated
A 33-year-old female mixed with AZ+BNT found a serious adverse reaction “broke blood vessels in the arm, dizziness and chills”
A woman in South Korea received the first dose of AZ vaccine and the second dose of Pfizer’s BNT vaccine. As a result, severe adverse reactions occurred.
Since August 7th, Korean domestic hospitals that have given the first dose of AZ vaccine will be opened for medical care, and the second dose can be mixed with Moderna vaccine. Playing Moderna is equivalent to all medical personnel in the first category. As long as they meet the AZ vaccination period for 10 weeks, they are eligible to play Moderna. A 33-year-old woman in South Korea received the first dose of the AZ vaccine and the second dose of the BNT vaccine. As a result, serious adverse reactions occurred, including rupture of blood vessels in the arm, dizziness, and chills.
According to South Korea’s “Dong-A Ilbo”, the 33-year-old woman lives in Bucheon, Gyeonggi Province. She received the AZ vaccine at a local hospital on June 11, and then received the second dose of BNT vaccine at the same hospital on July 27. However, at 3 pm on the day after the BNT vaccination, the woman developed symptoms such as ruptured blood vessels in her arm, dizziness, and chills, and then went to Incheon General Hospital for treatment. The detailed reasons need to be clarified.
The family member of the woman said: “She was very uncomfortable after the second dose, and she couldn’t work at all.” It was revealed that the woman had hives and chills after the first dose, but was told that it was okay at the time. , It is recommended to complete the vaccination. The Bucheon Health Bureau responded that they will notify the Korean Centers for Disease Control and Prevention Review Committee of the abnormal symptoms of the case, and further investigate whether the case is causally related to the vaccine.
According to the Yonhap News Agency, South Korea will vaccinate people aged 18 to 49 from the 6th to the 12th. Most of them will be vaccinated with BNT and the rest will be vaccinated with Moderna. The South Korean government pointed out that it will decide which vaccine to administer based on the arrival time of the two vaccines and the inventory of various vaccines at the vaccination site. At present, 9.82 million people in South Korea between the ages of 18 and 49 have completed the first dose of vaccination, with an inoculation rate of 43.3%.
(source:internet, reference only)
Disclaimer of medicaltrend.org
- Nearly 300 People Food Poisoning in Japanese 130-Year Restaurant
- FDA’s First Potential TIL Therapy Review Delayed: How to Understand FDA’s “Resource Constraints”?
- A Chinese Doctor Accused of Accepting Bribes Totaling US$166 Million
- Nuclear contaminated water: Japanese government paid bribes and corrected the IAEA report
- Top 20 Companies of Instruments and Medical Equipment In The World
- The first DMD gene therapy SRP-9001 may cost 4 million US dollars
- How long can the patient live after heart stent surgery?
